IDEAS home Printed from https://ideas.repec.org/a/eee/hepoli/v119y2015i11p1406-1414.html

Patients’ perceptions of generic drugs in Greece

Author

Listed:
  • Skaltsas, Leonora N.
  • Vasileiou, Konstantinos Z.

Abstract

The use of generic drugs is growing increasingly around the world and in Greece, in particular, in order to reduce pharmaceutical expenditure. However, patients’ perceptions and attitudes about generics have only partially been studied so far in Greece.

Suggested Citation

  • Skaltsas, Leonora N. & Vasileiou, Konstantinos Z., 2015. "Patients’ perceptions of generic drugs in Greece," Health Policy, Elsevier, vol. 119(11), pages 1406-1414.
    • Handle: RePEc:eee:hepoli:v:119:y:2015:i:11:p:1406-1414
    DOI: 10.1016/j.healthpol.2015.09.007
    as

    Download full text from publisher

    File URL: http://www.sciencedirect.com/science/article/pii/S0168851015002444
    Download Restriction: Full text for ScienceDirect subscribers only
    File URL: https://libkey.io/10.1016/j.healthpol.2015.09.007?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to

    for a different version of it.

    References listed on IDEAS

    as
    1. Kobayashi, Eriko & Karigome, Hiroshi & Sakurada, Tomoya & Satoh, Nobunori & Ueda, Shiro, 2011. "Patients' attitudes towards generic drug substitution in Japan," Health Policy, Elsevier, vol. 99(1), pages 60-65, January.
    2. Andersson, Karolina & Bergstrom, Gina & Petzold, Max G. & Carlsten, Anders, 2007. "Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals," Health Policy, Elsevier, vol. 81(2-3), pages 376-384, May.
    3. Simou, Effie & Koutsogeorgou, Eleni, 2014. "Effects of the economic crisis on health and healthcare in Greece in the literature from 2009 to 2013: A systematic review," Health Policy, Elsevier, vol. 115(2), pages 111-119.
    4. Else-Lydia Toverud & Katrin Hartmann & Helle Håkonsen, 2015. "A Systematic Review of Physicians’ and Pharmacists’ Perspectives on Generic Drug Use: What are the Global Challenges?," Applied Health Economics and Health Policy, Springer, vol. 13(1), pages 35-45, August.
    5. Heikkila, Reeta & Mantyselka, Pekka & Hartikainen-Herranen, Kaisa & Ahonen, Riitta, 2007. "Customers' and physicians' opinions of and experiences with generic substitution during the first year in Finland," Health Policy, Elsevier, vol. 82(3), pages 366-374, August.
    6. Geitona, Mary & Zavras, Dimitrios & Hatzikou, Magda & Kyriopoulos, John, 2006. "Generics market in Greece: The pharmaceutical industry's beliefs," Health Policy, Elsevier, vol. 79(1), pages 35-48, November.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Cristina Zerbini & Donata Tania Vergura & Beatrice Luceri, 2017. "Consumers? intention to buy generic drugs: Evidences from the Italian setting," MERCATI & COMPETITIVIT?, FrancoAngeli Editore, vol. 2017(1), pages 159-176.
    2. Nunes, Alexandre Morais & Ferreira, Diogo Cunha & de Matos, Andreia & Julião, Rui Miranda, 2020. "The Portuguese generic medicines market: What’s next?," Health Policy, Elsevier, vol. 124(4), pages 397-403.
    3. Lins Ferreira, Vinicius & Pereira da Veiga, Cássia Rita & Kudlawicz-Franco, Claudineia & Scalercio, Priscila & Ramires, Yohanna & Pontarolo, Roberto & Carvalho, Denise Maria W. & da Veiga, Claudimar , 2017. "Generic drugs in times of economic crisis: Are there changes in consumer purchase intention?," Journal of Retailing and Consumer Services, Elsevier, vol. 37(C), pages 1-7.
    4. Marina Economou & Lily Evangelia Peppou & Kyriakos Souliotis & Helen Lazaratou & Konstantinos Kontoangelos & Sofia Nikolaidi & Alexandra Palli & Costas N Stefanis, 2019. "Attitudes to depression and psychiatric medication amid the enduring financial crisis in Attica: Comparison between 2009 and 2014," International Journal of Social Psychiatry, , vol. 65(6), pages 479-487, September.
    5. Mondelo-García, Cristina & Mendoza, Elvia & Movilla-Fernández, María-Jesús & Coronado, Carmen, 2018. "Perceptions of pharmacists and physicians on generic substitution in a financial crisis context in Northwestern Spain: A qualitative study," Health Policy, Elsevier, vol. 122(12), pages 1316-1325.
    6. Zerbini, Cristina & Luceri, Beatrice & Vergura, Donata Tania, 2017. "Leveraging consumer’s behaviour to promote generic drugs in Italy," Health Policy, Elsevier, vol. 121(4), pages 397-406.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Timonen, Johanna & Karttunen, Pekka & Bengtström, Marina & Ahonen, Riitta, 2009. "The impact of generic substitution on the turnover and gross margin of pharmaceutical companies a survey 1 year and 5 years after the introduction of generic substitution in Finland," Health Policy, Elsevier, vol. 92(2-3), pages 116-123, October.
    2. Zerbini, Cristina & Luceri, Beatrice & Vergura, Donata Tania, 2017. "Leveraging consumer’s behaviour to promote generic drugs in Italy," Health Policy, Elsevier, vol. 121(4), pages 397-406.
    3. Chong, Chee Ping & March, Geoff & Clark, Alice & Gilbert, Andrew & Hassali, Mohamed Azmi & Bahari, Mohd Baidi, 2011. "A nationwide study on generic medicines substitution practices of Australian community pharmacists and patient acceptance," Health Policy, Elsevier, vol. 99(2), pages 139-148, February.
    4. Chong, Chee Ping & Hassali, Mohamed Azmi & Bahari, Mohd Baidi & Shafie, Asrul Akmal, 2010. "Evaluating community pharmacists' perceptions of future generic substitution policy implementation: A national survey from Malaysia," Health Policy, Elsevier, vol. 94(1), pages 68-75, January.
    5. Tavares, Lara Patrício & Zantomio, Francesca, 2017. "Inequity in healthcare use among older people after 2008: The case of southern European countries," Health Policy, Elsevier, vol. 121(10), pages 1063-1071.
    6. Vu, Trung V., 2020. "Economic complexity and health outcomes: A global perspective," Social Science & Medicine, Elsevier, vol. 265(C).
    7. Dimitra Sifaki-Pistolla & Vasiliki Eirini Chatzea & Enkeleint A. Mechili & Filippos Koinis & Vassilis Georgoulias & Christos Lionis & Nikos Tzanakis, 2022. "Spatio-Temporal Variation of Lung Cancer in Crete, 1992–2013. Economic or Health Crisis?," IJERPH, MDPI, vol. 19(19), pages 1-10, September.
    8. Moheddine Younsi & Marwa Bechtini, 2024. "Financing Health Systems in Developing Countries: the Role of Government Spending and Taxation," Journal of the Knowledge Economy, Springer;Portland International Center for Management of Engineering and Technology (PICMET), vol. 15(3), pages 13182-13210, September.
    9. Afentoula G. Mavrodi & Vassilis H. Aletras, 2019. "Preliminary Results of a Healthcare Contingent Valuation Study in Greece," International Journal of Finance, Insurance and Risk Management, International Journal of Finance, Insurance and Risk Management, vol. 9(3-4), pages 3-16.
    10. Perotti, Roberto, 2018. "The human side of austerity: health spending and outcomes during the Greek crisis," CEPR Discussion Papers 13131, C.E.P.R. Discussion Papers.
    11. Timokleia Kousi & Lefkothea-Christina Mitsi & Jean Simos, 2021. "The Early Stage of COVID-19 Outbreak in Greece: A Review of the National Response and the Socioeconomic Impact," IJERPH, MDPI, vol. 18(1), pages 1-17, January.
    12. Toon van der Gronde & Carin A Uyl-de Groot & Toine Pieters, 2017. "Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-34, August.
    13. Hassali, Mohamed Azmi & Wong, Zhi Yen & Alrasheedy, Alian A. & Saleem, Fahad & Mohamad Yahaya, Abdul Haniff & Aljadhey, Hisham, 2014. "Perspectives of physicians practicing in low and middle income countries towards generic medicines: A narrative review," Health Policy, Elsevier, vol. 117(3), pages 297-310.
    14. Giovanni Piumatti, 2020. "Longitudinal Trends in Self-Rated Health During Times of Economic Uncertainty in Italy," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 148(2), pages 599-633, April.
    15. Dimitra Sifaki-Pistolla & Enkeleint A. Mechili & Evangelos Melidoniotis & Alexandros Argyriadis & Evridiki Patelarou & Vasiliki-Eirini Chatzea, 2022. "Participatory Action Research for Tackling Distress and Burnout in Young Medical Researchers: Normative Beliefs before and during the Greek Financial Crisis," IJERPH, MDPI, vol. 19(17), pages 1-12, August.
    16. Pengpei Liu & Xuelei Yang & Xingrong Liu, 2025. "Assessing the mental health implications of carbon trading policies: evidence from urban China," Humanities and Social Sciences Communications, Palgrave Macmillan, vol. 12(1), pages 1-13, December.
    17. Suzanne Dunne & Bill Shannon & Colum Dunne & Walter Cullen, 2014. "Patient Perceptions of Generic Medicines: A Mixed-Methods Study," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 7(2), pages 177-185, June.
    18. Grigorakis, Nikolaos & Floros, Christos & Tsangari, Haritini & Tsoukatos, Evangelos, 2016. "Out of pocket payments and social health insurance for private hospital care: Evidence from Greece," Health Policy, Elsevier, vol. 120(8), pages 948-959.
    19. Ilias‐Ioannis Kyriopoulos & Dimitris Zavras & Antonis Charonis & Kostas Athanasakis & Elpida Pavi & John Kyriopoulos, 2016. "Indebtedness, Socioeconomic Status, and Self‐Rated Health: Empirical Evidence From Greece," Poverty & Public Policy, John Wiley & Sons, vol. 8(4), pages 387-397, December.
    20. Giancarlo MANZI & Pier Alda FERRARI & Sonia STEFANIZZI, 2017. "On the Impact of the European Union in Citizens’ Perception of Quality of Life," Departmental Working Papers 2017-08, Department of Economics, Management and Quantitative Methods at Università degli Studi di Milano.

    More about this item

    Keywords

    ;
    ;
    ;
    ;
    ;
    ;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:119:y:2015:i:11:p:1406-1414. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.